3rd GLP-1 Based Therapeutics Summit 2026 14th April 2026 - April 16, 2026 The 3rd GLP-1 Based Therapeutics Summit is the essential industry forum dedicated to solving the critical challenges of GLP-1 combinations, mastering tolerability, drug delivery, and seizing the multi-billion dollar opportunity in non-obesity indications
GIP is a hormone produced by the small intestine that increases insulin release after eating food
Adverse events caused treatment discontinuation in 4.3%, 7.1%, 6.2%, and 2.6% of participants receiving 5-mg, 10-mg, 15-mg tirzepatide doses and placebo, respectively [49]
This could lead to new ways to identify and treat aggressive melanoma
Statements Author contributions WW and JL designed the review